KKR Acquires Majority Stake in HealthCare Royalty Partners (HCRx)
July 30, 2025
KKR & Co. Inc. has acquired a majority ownership stake in HealthCare Royalty Partners (HCRx), a Stamford-based biopharma royalty acquisition firm. HCRx's CEO Clarke Futch will remain as CEO with a minority interest, and the HCRx team will collaborate with KKR's healthcare platform to expand KKR's life sciences and royalty financing capabilities.
- Buyers
- KKR & Co. Inc.
- Targets
- HealthCare Royalty Partners (HCRx)
- Industry
- Financial Services
- Location
- Connecticut, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
KKR Acquires Majority Stake in Healthcare Global Enterprises from CVC
February 24, 2025
Healthcare Services
KKR funds have agreed to acquire up to a 54% stake in Healthcare Global Enterprises (HCG) from CVC Asia V for a purchase price of INR 445 per share (deal value up to about US$400m). The transaction transfers majority ownership to KKR to support HCG's continued network growth, clinical and R&D expansion, and digital transformation; the deal is expected to close in Q3 2025 subject to regulatory approvals.
-
KKR to Acquire Healthium MedTech from Apax Funds
May 6, 2024
Medical Devices
KKR (through funds it manages) has signed definitive agreements to acquire a controlling interest in Healthium MedTech Ltd. from funds advised by Apax Partners. The transaction, expected to close in Q3 2024 subject to regulatory approvals, will support Healthium's next phase of global growth and product/market expansion.
-
KKR and Norwest Venture Partners Invest in Infinx
May 21, 2024
Healthcare Services
KKR (via a fund managed by the firm) has agreed to make a minority investment in Infinx Services Private Limited, an AI-driven healthcare revenue cycle management (RCM) provider based in Mumbai. Norwest Venture Partners, an existing investor, participated in the financing; proceeds will be used to accelerate growth, expand AI and analytics capabilities, broaden market reach in the U.S., and support bolt-on acquisitions.
-
KKR Acquires Majority Stake in apexanalytix from Carousel Capital
June 6, 2022
Data & Analytics
KKR has signed a definitive agreement to acquire a majority interest in apexanalytix, a supply-chain software, data and analytics provider. Carousel Capital will remain a significant minority owner; KKR’s investment is intended to accelerate apexanalytix’s global expansion, product development and talent recruitment.
-
Creach Family Holdings Acquires HealthRev Partners
December 4, 2024
Healthcare Services
Creach Family Holdings, a privately held family investment firm, has acquired HealthRev Partners, a technology-enabled revenue cycle management (RCM) provider serving the home health and hospice market. The acquisition will integrate HealthRev's RCM capabilities with Creach's portfolio EMR platform Careficient to offer a combined suite of clinical and billing solutions for home health and hospice providers.
-
CareRx Acquires Hogan Pharmacy Partners Ltd.
March 30, 2022
Healthcare Services
CareRx Corporation entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd., a technology-enabled long-term care pharmacy serving about 725 residents in Ontario. The consideration includes C$2.2 million in CareRx common shares and a C$2.2 million vendor take-back note; CareRx expects the deal to close in May 2022 and to be immediately accretive to earnings while extending its technology and service capabilities for seniors' congregate care.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.